+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

COVID-19 Impact on BioNTech SE

  • PDF Icon

    Company Profile

  • 31 Pages
  • October 2020
  • GlobalData
  • BioNTech SE
  • ID: 5187172
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Summary

BioNTech SE (BioNTech) is a biotechnology platform company with pipeline programs for the treatment of cancer and prevention of infectious disease. The company most prominent platform is for the development of mRNA vaccines.

Scope
  • This PowerPoint based report gives an important expert analysis on how COVID-19 will affect BioNTech. Findings are based on the industry’s most comprehensive platform the Pharma Intelligence Center, including Deals, News, Drugs, Sales, Clinical Trials database and recent analysis.

Reasons to Buy
  • An overview of how BioNTech will be affected by the COVID-19 pandemic.

Table of Contents

Executive Summary
Company Overview
  • Key Stats
  • SWOT Analysis

Sales Overview
  • Regional Analysis
  • COVID-19 Spread Versus Location of BioNTech Trials
  • COVID-19 Versus non-COVID Trials
  • Reaction of COVID-19
  • BNT-162b2
  • Insights Exclusive Intel: BioNTech

Global Analyst Consensus Sales Forecast
  • Upcoming Events
  • Disrupted Trials
  • Resumed Trials
  • Recent Deal Activity
  • Key Findings

Appendix
  • Methodology
  • About the Publisher
  • Contacts

Companies Mentioned

A selection of companies mentioned in this report includes:

  • BioNTech SE

Related Topics

Copyright © 2002-2023 Research and Markets. All Rights Reserved.